EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2024 for the clinical practice of hereditary colorectal cancer

Kohji Tanakaya, Tatsuro Yamaguchi, Keiji Hirata, Masayoshi Yamada, Kensuke Kumamoto, Yasuki Akiyama, Kei Ishimaru, Koichi Okamoto, Yuko Kawasaki, Keigo Komine, Akira Sakamoto, Kunitoshi Shigeyasu und 37 weitere

International Journal of Clinical Oncology · 2026-01 · 31 (1) · 1-66

DOI: 10.1007/s10147-025-02892-1 ↗

Kurz gefasst

Leitlinie in der Zeitschrift International Journal of Clinical Oncology, online erschienen am 10.11.2025. Verfasst von Kohji Tanakaya und 48 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, National Hospital Organization Iwakuni Clinical Center, 1-1-1 Atago-Machi, Iwakuni, 740-8510, Japan. tanakaya.kouji.tb@mail.ho…. Hauptthemen laut MEDLINE: Adenomatous Polyposis Coli, Colorectal Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 473 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japanese Society for Cancer of the Colon and Rectum.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Approximately 5% of all colorectal cancers have a strong genetic component and are classified as hereditary colorectal cancer (HCRC). Some of the unique features commonly seen in HCRC cases include early age of onset, synchronous/metachronous cancer occurrence, and multiple cancers in other organs. These characteristics require different management approaches, including diagnosis, treatment or surveillance, from those used in the management of sporadic colorectal cancer. Accurate diagnosis of HCRC is essential because it enables targeted surveillance and risk reduction strategies that improve patient outcomes. Recent genetic advances revealed several causative genes for polyposis and non-polyposis syndromes. The Japanese Society for Cancer of the Colon and Rectum (JSCCR) first published guidelines for the management of HCRC in 2012, with subsequent revisions every 4 years. The 2024 update to the JSCCR guidelines for HCRC was developed by meticulously reviewing evidence from systematic reviews and the consensus of the JSCCR HCRC Guidelines Committee, which includes representatives from patient advocacy groups for FAP and Lynch syndrome. These guidelines provide an up-to-date summary of HCRC, along with clinical recommendations for managing FAP and Lynch syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenomatous Polyposis ColiColorectal NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisHumansJapan

Stichwörter der Autor:innen

Familial adenomatous polyposisGuidelinesHereditary colorectal cancerLynch syndrome

Autor:innen und Institutionen

  • Department of Surgery, National Hospital Organization Iwakuni Clinical Center, 1-1-1 Atago-Machi, Iwakuni, 740-8510, Japan. tanakaya.kouji.tb@mail.hosp.go.jp.
  • Department of Clinical Genetics, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Department of Surgery 1, University of Occupational and Environmental Health, Kitakyushu, Japan.
  • Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Genome Medical Science and Medical Genetics, Faculty of Medicine, Kagawa University, Kita-Gun, Japan.
  • Division of Gastrointestinal Surgery and Surgical Oncology, Graduate School of Medicine, Ehime University, Toon, Japan.

Förderung

  • Japanese Society for Cancer of the Colon and Rectum

Zitieren

APA

Tanakaya, K., Yamaguchi, T., Hirata, K., Yamada, M., Kumamoto, K., Akiyama, Y., Ishimaru, K., Okamoto, K., Kawasaki, Y., Komine, K., Sakamoto, A., Shigeyasu, K., Shibata, Y., Shimamoto, Y., Shimodaira, H., Sekine, S., Takao, A., Takao, M., Takamizawa, Y., …, & Japanese Society for Cancer of the Colon, Rectum (2026). Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2024 for the clinical practice of hereditary colorectal cancer. International Journal of Clinical Oncology, 31(1), 1-66. https://doi.org/10.1007/s10147-025-02892-1

Vancouver

Tanakaya K, Yamaguchi T, Hirata K, Yamada M, Kumamoto K, Akiyama Y, et al. Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2024 for the clinical practice of hereditary colorectal cancer. International Journal of Clinical Oncology. 2026;31(1):1-66. doi:10.1007/s10147-025-02892-1

BibTeX
@article{Tanakaya2026,
  author = {Tanakaya, Kohji and Yamaguchi, Tatsuro and Hirata, Keiji and Yamada, Masayoshi and Kumamoto, Kensuke and Akiyama, Yasuki and Ishimaru, Kei and Okamoto, Koichi and Kawasaki, Yuko and Komine, Keigo and Sakamoto, Akira and Shigeyasu, Kunitoshi and Shibata, Yoshiko and Shimamoto, Yusaku and Shimodaira, Hideki and Sekine, Shigeki and Takao, Akinari and Takao, Misato and Takamizawa, Yasuyuki and Takeuchi, Yoji and Tanabe, Noriko and Taniguchi, Fumitaka and Chino, Akiko and Cho, Hourin and Doi, Satoru and Nakajima, Takeshi and Nakamori, Sakiko and Nakayama, Yoshiko and Nagasaki, Toshiya and Hasumi, Hisashi and Banno, Kouji and Hinoi, Takao and Fujiyoshi, Kenji and Horimatsu, Takahiro and Masuda, Kenta and Miguchi, Masashi and Mizuuchi, Yusuke and Miyakura, Yasuyuki and Mutoh, Michihiro and Yoshioka, Takahiro and Tanaka, Shinji and Sakamoto, Kazuhiro and Sakamaki, Kentaro and Itabashi, Michio and Ishida, Hideyuki and Tomita, Naohiro and Sugihara, Kenichi and Ajioka, Yoichi and Japanese Society for Cancer of the Colon, Rectum, Japanese Society for Cancer of the Colon, Rectum},
  title = {Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2024 for the clinical practice of hereditary colorectal cancer},
  journal = {International Journal of Clinical Oncology},
  year = {2026},
  volume = {31},
  number = {1},
  pages = {1--66},
  doi = {10.1007/s10147-025-02892-1}
}
Kostenlos starten →